Highly conserved epitope domain in major core protein p24 is structurally similar among human, simian and feline immunodeficiency viruses

References

1. Adachi A., Gendelman H. E., Koenig S., Folks T., Willey R., Rabson A., Martin M. A. 1986; Production of an acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. Journal of Virology 59:284–291
   [Google Scholar]
2. Argos P. 1989; A possible homology between immunodeficiency virus p24 core protein and picornaviral VP2 coat protein: prediction of HIV p24 antigenic sites. EMBO Journal 8:779–785
   [Google Scholar]
3. Barré-Sinoussi F., Chermann J. C., Rey F., Nugeyre M. T., Chamaret S., Gruest J., Dauguet C., Axler-Blin C., Vézinet-Brun F., Rouzioux C., Rozenbaum W., Montagnier L. 1983; Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220:868–871
   [Google Scholar]
4. Carpio E., Duarte C., Hinkula J., Broliden P.-A., Rosen J., Campal A., Gavilondo J., Wahren B., Jondal M. 1991; Monoclonal antibodies to conserved regions of the major core protein (gag24) of HIV-1 and HIV-2. AIDS Research and Human Retroviruses 7:97–101
   [Google Scholar]
5. Coates A. R. M., Cookson J., Barton G. J., Zwelebil M. J., Sternberg M. J. E. 1987; AIDS vaccine predictions. Nature, London 326:549–550
   [Google Scholar]
6. Francis M. J., Fry C. M., Rowlands D. J., Bittle J. L., Houghten R. A., Lerner R. A., Brown F. 1987; Immune response to uncoupled peptides of foot and mouth disease virus. Immunology 1:1–6
   [Google Scholar]
7. Fukasawa M., Miura T., Hasegawa A., Morikawa S., Tujimoto H., Miki K., Kitamura T., Hayami M. 1988; Sequence of simian immunodeficiency virus from African green monkey, a new member of the HIV/SIV group. Nature, London 333:457–461
   [Google Scholar]
8. Geysen H. M., Meloen R. H., Berteling S. J. 1984; Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proceedings of the National Academy of Sciences, U.S.A. 81:3998–4002
   [Google Scholar]
9. Ikuta K., Morita C., Miyake S., Ito T., Okabayashi M., Sano K., Nakai M., Hirai K., Kato S. 1989; Expression of human immunodeficiency virus type 1 (HIV-1) gag antigens on the surface of a cell line persistently infected with HIV-1 that highly expresses HIV-1 antigens. Virology 170:408–417
   [Google Scholar]
10. Langedijk J. P. M., Schalken J. J., Tersmette M., Huisman J. G., Meloen R. H. 1990; Location of epitopes on the major core protein p24 of human immunodeficiency virus. Journal of General Virology 71:2609–2614
    [Google Scholar]
11. Leclerc C., Deriaud E., Mimic V., van der Werf S. 1991; Identification of a T-cell epitope adjacent to neutralization antigenic site 1 of poliovirus type 1. Journal of Virology 65:711–718
    [Google Scholar]
12. Matsuo K., Yamaguchi R., Yamazaki A., Tasaka H., Yamada T. 1988; Cloning and expression of the Mycobacterium bovis BCG gene for extracellular a antigen. Journal of Bacteriology 170:3847–3854
    [Google Scholar]
13. Miyazawa T., Fukasawa M., Hasegawa A., Maki N., Ikuta K., Takahashi E., Hayami M., Mikami T. 1991; Molecular cloning of a novel isolate of feline immunodeficiency virus biologically and genetically different from the original U.S. isolate. Journal of Virology 65:1572–1577
    [Google Scholar]
14. Morikawa S., Booth T. F., Bishop D. H. L. 1991; Analyses of the requirements for the synthesis of virus-like particles by feline immunodeficiency virus gag using baculovirus vectors. Virology 183:288–297
    [Google Scholar]
15. Niedrig M., Hinkula J., Harthus H.-P., Broker M., Hopp L., Pauli G., Wahren B. 1991; Characterization of murine monoclonal antibodies directed against the core proteins of human immunodeficiency virus types 1 and 2. Journal of Virology 65:4529–4533
    [Google Scholar]
16. Nishino Y., Ohki K., Kimura T., Morikawa S., Mikami T., Ikuta K. 1992; Major core proteins, p24s, of human, simian, and feline immunodeficiency viruses are partly expressed on the surface of the virus-infected cells. Vaccine (in press)
    [Google Scholar]
17. Nixon D. F., Townsend A. R. M., Elvin J. G., Rizza C. R., Gallwey J., McMichael A. J. 1988; HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature, London 336:484–487
    [Google Scholar]
18. Palker T. J., Clark M. E., Langlois A. J., Matthews T. J., Weinhold K. J., Randall R. R., Bolognesi D. P., Haynes B. F. 1988; Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. Proceedings of the National Academy of Sciences, U.S.A. 85:1932–1936
    [Google Scholar]
19. Pederson N. C., Ho E. W., Brown M. L., Yamamoto J. K. 1987; Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235:790–793
    [Google Scholar]
20. Popovic M., Sarngadharan M. G., Read E., Gallo R. C. 1984; Detection, isolation, and continuous production of cytopathic retrovirus (HTLV-III) from patients with AIDS and pre-AIDS. Science 224:497–500
    [Google Scholar]
21. Ratner L., Haseltine W., Patarca R., Livak K. J., Starcich B., Josephs S. F., Doran E. R., Rafalski J. A., Whitehorn E. A., Baumeister K., Ivanoff L., Petteway S. R. Jr, Pearson M. L., Lautenberger J. A., Papas T. S., Ghrayeb J., Chang N. T., Gallo R. C., Wong-Staal F. 1985; Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature, London 313:277–284
    [Google Scholar]
22. Rook A. H., Lane H. C., Folks T., McCoy S., Alter H., Fauci A. S. 1987; Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells. Journal of Immunology 138:1064–1067
    [Google Scholar]
23. Rothbard J. B., Taylor W. R. 1988; A sequence pattern common to T cell epitopes. EMBO Journal 7:93–100
    [Google Scholar]
24. Ruther U., Muller-Hill B. 1983; Easy identification of cDNA clones. EMBO Journal 2:1791–1794
    [Google Scholar]
25. Schrier R. D., Gnann J. W. Jr, Landes R., Lockshin C., Richman D., McCutchan A., Kennedy C., Oldstone M. B. A., Nelson J. A. 1989; T cell recognition of HIV synthetic peptides in a natural infection. Journal of Immunology 142:1166–1176
    [Google Scholar]
26. Takahashi H., Cohen J., Hqsmalin A., Cease K. B., Houghten R., Cornette J. L., DeLisi C., Moss B., Germain R. N., Berzofsky J. A. 1988; An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. Proceedings of the National Academy of Sciences, U.S.A. 85:3105–3109
    [Google Scholar]
27. Talbott R. L., Sparger E. E., Lovelace K. M., Fitch W. M., Pedersen N. C., Luciw P. A., Elder J. H. 1989; Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proceedings of the National Academy of Sciences, U.S.A. 86:5743–5747
    [Google Scholar]
28. Weber J. N., Clapham P. R., Weiss R. A., Parker D., Roberts C., Duncan J., Weller I., Carne C., Tedder R. S., Pinching A. J., Cheingsong-Popov R. 1987; Human immunodeficiency virus infection in two cohorts of homosexual men: neutralising sera and association of anti-gag antibody with prognosis. Lancet i:119–122
    [Google Scholar]
29. Yamaguchi R., Matsuo K., Yamazaki A., Kagawa H., Nagai S., Yamada T. 1991; Fusion protein based epitope mapping of the MPB57 protein from Mycobacterium bovis BCG and its epitope insertion into the native protein. Canadian Journal of Microbiology 37:7–13
    [Google Scholar]